Stellate DNA
Stellate DNA, founded in 2020, is a Cambridge-based IP and tech provider specializing in proprietary DNA donor synthesis.
Founded
2020Stellate DNA, founded in 2020, is a Cambridge-based IP and tech provider specializing in proprietary DNA donor synthesis.
Stellate DNA, founded in 2020 and headquartered in Cambridge, Massachusetts, is an intellectual property and technology provider specializing in proprietary DNA donor synthesis. The company's core mission is to advance genetic engineering through innovative DNA donor technologies. Stellate DNA offers the Gatalyst™ platform, an integrated suite of technologies designed to produce high-efficiency, low-toxicity, single-stranded DNA donors for large-size homology-directed repair (HDR) knock-ins using the CRISPR-Cas9 system. Their products cater to researchers and biotech companies focused on genetic modifications and therapeutic developments.
Notable affiliated individuals and investors include key figures from the biotech industry, though specific names are not publicly disclosed. Stellate DNA's significant achievements include the successful development and deployment of their Gatalyst™ platform, which has been recognized for its efficiency and scalability in genetic editing applications. The company's impact is seen in its contributions to advancing CRISPR technology, enabling more precise and effective genetic modifications, which hold promise for various medical and scientific breakthroughs.
Companies similar to Stellate DNA include Stellaromics, Stel Technologies, Twist Bioscience and Inscripta.
Stellate DNA was founded in 2020.
Stellate DNA's headquarters is located in Cambridge, MA, US.
Stellate DNA's most recent funding round was for $256k (USD) in July 2021.
As of Jul 15, 2021, Stellate DNA has raised a total of $256k (USD).
Stellate DNA has 5 employees as of Feb 4, 2024.
Twist Bioscience
